Biotech
CDMO Samsung Bio Secures Record $1.24 Billion Biopharma Manufacturing Contract, Raising Total 2024 Deal Value to Over $3.3 Billion
2024-10-23
Key Trends in the Pharmaceutical Pipeline for 2024 — Part II: U.S. and China Compete for Top Position in the Global Drug Development Landscape
2024-10-23
A Global Perspective on Australia’s Biotechnology Industry: Key Insights Ahead of AusBiotech 2024
2024-10-22
JPMA on Japan’s Biotech Industry: Cancer, Cardiovascular, and Aging Lead Diseases; Antibody, Cell, and Gene Therapies Top the Innovation List
2024-10-17
Industry Giant Google Backs BIODND—A Precise Life Science Platform Leveraging AI for Efficient Industry Decision-Making
2024-10-17
Illumina Stepping It Up in Gene Sequencing Innovation with Global Launch of New Tech—MiSeq i100 Series in Taipei
2024-10-16
Biogen and UCB Promising Phase-III Trial Data for Lupus; CAR T-Cell Therapy Another Autoimmune Treatment Avenue
2024-09-25
Illumina’s IVD Biomarker Test Becomes the First FDA-approved Pan-cancer Companion Diagnostics Kit
2024-09-11
LATEST
Strengthening Biotech Ties: Highlights from the BioConnect Forum and Future Collaboration between Taiwan and Australia
2024-10-31
AusBiotech 2024 Opening Ceremony: From Local to Global – Shaping the Future of Life Sciences and Biotech in Australia
2024-10-30
AusBiotech 2024 to Highlight Global Areas of Interest, Current Trends, and Research Directives in Australia’s Diverse Biotech Industry
2024-10-25